DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Pilot Study of Continuing Aspirin Versus Switching to Clopidogrel After Stroke or Transient Ischemic Attack

Information source: University of California, San Diego
Information obtained from ClinicalTrials.gov on June 20, 2008
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Transient Ischemic Attack; Stroke; Aspirin; Clopidogrel

Intervention: aspirin versus clopidogrel (Drug)

Phase: Phase 1

Status: Withdrawn

Sponsored by: University of California, San Diego

Official(s) and/or principal investigator(s):
Matt B Jensen, MD, Principal Investigator, Affiliation: UCSD Stroke Center

Summary

Pilot study of continuing aspirin versus switching to clopidogrel after stroke or transient ischemic attack.

Clinical Details

Official title: Pilot Study of Continuing Aspirin Versus Switching to Clopidogrel After Stroke or Transient Ischemic Attack

Study design: Prevention, Randomized, Open Label, Active Control, Parallel Assignment, Safety/Efficacy Study

Primary outcome: mRS at three months.

Secondary outcome: Incidence of stroke at three months, bleeding events.

Detailed description: Pilot study of continuing aspirin versus switching to clopidogrel after stroke or transient ischemic attack.

Eligibility

Minimum age: 18 Years. Maximum age: N/A. Gender(s): Both.

Criteria:

Inclusion Criteria:

- Age 18 and older.

- Stroke or transient ischemic attack (TIA) while taking aspirin within one week of

consent.

- Women of child-bearing potential will be included only if there is a negative

pregnancy test and they agree to birth control during the treatment period.

Exclusion Criteria:

- Any medical indication for a specific antiplatelet agent (aspirin, clopidogrel,

ticlopidine, aggrenox), or an indication for a combination of antiplatelet agents.

- Any medical indication for anticoagulation, except subcutaneous heparin for deep vein

thrombosis prophylaxis.

- Allergy to aspirin or clopidogrel.

Locations and Contacts

UCSD Hillcrest, San Diego, California 92103, United States

UCSD, San Diego, California 92103, United States

Additional Information

Starting date: August 2006
Ending date: March 2007
Last updated: March 30, 2007

Page last updated: June 20, 2008

-- advertisement -- The American Red Cross
We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2009